Company Overview and News
For investors snowed under an avalanche of numbers during the recent earnings season, we have spotted a dozen small cap companies (market cap less than Rs 1000 crore) that you may like to keep on your radar.
The Nifty and the Sensex were still trading in the red with the Nifty shedding 16.85 points at 10346 while the Sensex was down 29 points at 33237.48. The CNX PSU bank index was the top loser which fell 1.23 percent led by Union Bank of India, Allahabad Bank, Andhra Bank and Punjab National Bank.
The Indian benchmark indices, Nifty and the Sensex were trading on a negative note with the Nifty shedding 9 points at 10354 while the Sensex was down 14.84 points at 33250.48. The midcap index was trading marginally in the green, up 1.14 percent led by GMR Indra, India Cements, Jain Irrigation and Sun TV Network.
The Nifty as well as the Sensex continued to hold on to their respective morning gains with the Nifty adding 50 points or 0.49 percent while the Sensex gained 0.43 percent and was trading at 33,296.17. The Nifty midcap index continued to outperform the broader indices gaining 1.3 percent led by MRF, Bata India, Just Dial, IDBI Bank, Oriental Bank of Commerce and Voltas.
The Indian equity market opened the week on a bullish note with the Nifty jumping 55.40 points or 0.54 percent while the Sensex gained 164.59 points at 33,2321.81. The Nifty midcap index was the outperforming sector which was up 1.18 percent led by Union Bank of India, Syndicate Bank, Bata India and Allahabad Bank.
The Nifty as well as the Sensex in the afternoon trade on Friday held on to their respective gains with the Nifty trading 0.05 percent higher at 10349.30 while the Sensex was up 90.35 points at 33237.71 largely dragged by Bank Nifty which fell 0.26 percent.
The Nifty in the afternoon trade on Friday was trading in the positive territory, up 9 points at 1035 and the Sensex gained over 100 points at 33259.21. Bank Nifty was the drag which fell 0.47 percent. The top loser from the banking index were Yes Bank which tanked over 7 percent while PNB slipped over 5 percent. Kotak Mahindra Bank however was up 2.17 percent.
It was the day that belonged to the bulls with the Nifty50 soaring close to 100 points or 0.95 percent while the Sensex jumped 468 points at 33075 in the afternoon trade. Bank Nifty charged ahead and was the distinct outperformer with the index jumping 3.64 percent after the government on Tuesday approved recapitalization plans of Rs 2 lakh, 11 thousand crore for the ailing PSU banks.
The Nifty and the Sensex continued to trade on a strong note adding further gains to the morning trade with the Nifty50 adding 0.57 percent or 58.25 points while the Sensex added 316 points at 32923 in the afternoon trade. Bank Nifty charged ahead and was the distinct outperformer with the index jumping 2.33 percent after the government on Tuesday approved recapitalization plans of Rs 2 lakh, 11 thousand crore for the ailing PSU banks.
The Indian equity market witnessed a strong opening on Wednesday morning with the Nifty up 0.46 percent or 46.40 points while the Sensex added 236 points in the morning trade. Bank Nifty was the standout sector with the index jumping 1.9 percent after the government approved recapitalization plans of Rs 2 lakh, 11 thousand crore for the ailing PSU banks.
In the afternoon trade the Nifty was trading at 10206.80, up 21.95 points while the Sensex was up 71.57 points at 32578.29. The bank Nifty was the outperforming sector led by Punjab National Bank which jumped 6.37 percent while Bank of India gained 4.08 percent. State Bank of India and Canara Bank were the othet top gainers which added over 2 percent each. However, IndusInd Bank was the drag wich slipped 2.
Nifty and the Sensex held on to their respective morning gains on Tuesday afternoon with the Nifty adding 33.25 points at 10218.10 while the Sensex gained 0.31 percent, up 96 points at 32602. The midcap index outperformed the broader indices, up 0.7 percent Andhra Bank, Karnataka Bank, Canara Bank, Reliance Capital and Reliance Infra.
The Indian benchmark indices, Nifty as well as the Sensex were trading on a positive note on Tuesday morning trade with the Nifty adding 26 points at 10212 while the Sensex gained 0.31 percent, up 101 points at 32613.01. Bank Nifty was was up 0.75 percent led by Yes Bank which gained 2.29 percent followed by Bank of Baroda, PNB and Axis Bank. ICICI Bank was up over 1 percent in the morning trade.
NEW YORK, July 10, 2017 /PRNewswire/ -- This report analyzes the worldwide markets for Explosives in Metric Tons and in US$ Million by the following Product Segments: Blasting Agents, Propellants, Pyrotechnics, and Other Explosives. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin American. Annual estimates and forecasts are provided for the period 2015 through 2022.
Disclaimer: The contents herein is specifically prepared by ‘Dalal Street Investment Journal’, and is for your information & personal consumption only. India Infoline Limited or Dalal Street Investment Journal do not guarantee the accuracy, correctness, completeness or reliability of information contained herein and shall not be held responsible.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...